FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092728 [Registered on: 08/08/2025] Trial Registered Prospectively
Last Modified On: 08/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Yoga & Naturopathy 
Study Design  Single Arm Study 
Public Title of Study   This is a study of beneficial effects of yoga on the quality of life and stress in children who have experienced cancer and blood disorders and also their family members.  
Scientific Title of Study   Effect of yoga practice on health related quality of life at 12 weeks in paediatric haemat-oncological patients aged 3-18 years and their caregivers 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  K Prasanna Venkatesh 
Designation  PG resident 1st year 
Affiliation  ESIC PGIMSR Hospital 
Address  Pediatric hemato oncology division, Pediatric ward- unit II, first floor D3 Building, Pediatric Department, ESI PGIMSR Basaidarapur ,Ring road , New Delhi

New Delhi
DELHI
110015
India 
Phone  9654411182  
Fax    
Email  drprasannaesic@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kanwaljeet Kaur Chopra 
Designation  Senior Specialist & Associate Professor 
Affiliation  ESIC PGIMSR Hospital 
Address  Incharge Pediatric Hemato Oncology Division, dept of Pediatrics, ESI PGIMSR Basaidarapur ,Ring road , New Delhi

New Delhi
DELHI
110015
India 
Phone  9899991596  
Fax    
Email  drkanwaljeetkaur@gmail.com  
 
Details of Contact Person
Public Query
 
Name  K Prasanna Venkatesh 
Designation  PG resident 1st year 
Affiliation  ESIC PGIMSR Hospital 
Address  Pediatric ward, Unit 2, First floor, D3 Building, Pediatric Hemato Oncology division, Dept of Pediatrics, ESI PGIMSR Basaidarapur ,Ring road , New Delhi

New Delhi
DELHI
110015
India 
Phone  9654411182  
Fax    
Email  drprasannaesic@gmail.com  
 
Source of Monetary or Material Support  
Not Applicable 
 
Primary Sponsor  
Name  ESIC Basaidarapur 
Address  ESI PGIMSR Basaidarapur , Ring Road , New Delhi 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
Not Applicable  Not Applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
K Prasanna Venkatesh  ESIC Hospital and PGIMSR Basaidarapur  Paeditric ward unit 2 , 1st floor , D3 building , paediatric hematoncology division, Department of Paediatrics, ESI PGIMSR Ring Road , New Delhi
West
DELHI 
9654411182

drprasannaesic@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC ESI-PGIMSR Basaidarapur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C812||Mixed cellularity Hodgkin lymphoma, (2) ICD-10 Condition: C910||Acute lymphoblastic leukemia [ALL], (3) ICD-10 Condition: C921||Chronic myeloid leukemia, BCR/ABL-positive, (4) ICD-10 Condition: C819||Hodgkin lymphoma, unspecified, (5) ICD-10 Condition: D561||Beta thalassemia, (6) ICD-10 Condition: D569||Thalassemia, unspecified, (7) ICD-10 Condition: D552||Anemia due to disorders of glycolytic enzymes, (8) ICD-10 Condition: D67||Hereditary factor IX deficiency, (9) ICD-10 Condition: D66||Hereditary factor VIII deficiency, (10) ICD-10 Condition: D693||Immune thrombocytopenic purpura, (11) ICD-10 Condition: D644||Congenital dyserythropoietic anemia, (12) ICD-10 Condition: C946||Myelodysplastic disease, not classified, (13) ICD-10 Condition: D648||Other specified anemias,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Comparator Not applicable  Comparator not applicable 
Intervention  Yoga Practice for 12 weeks   Patients and their caregivers will be asked to do personalized yoga as advised by certified yoga instructor in the hospital. The patients and their caregivers will practice yoga for 5 days a week for 10 or 30 minutes each day depending on the age and they will be keeping the daily log in a diary. It will be 3 times a week online followup by hospital visit of the patient every 3 weekly  
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  18.00 Year(s)
Gender  Both 
Details  Subjects diagnosed with oncological or chronic haematological conditions undergoing active treatment such as chemotherapy, radiotherapy, blood transfusions, factor replacement, chelation therapy, and post-treatment monitoring etc or survivors of childhood cancer conforming to the following
1 At least one parent or primary caregiver of each participating child is available
2 At least one caregiver and/or the child is able to comprehend the technique of yoga and respond to questionnaires.

 
 
ExclusionCriteria 
Details  1 Patients with medical conditions or contraindications to physical activity such as hemodynamically unstable, dyselectrolytemia, febrile neutropenia, platelet count less than 50000 per µL or with bleeding, haemoglobin less than 7 g per dL, bone or soft tissue injury, tumour lysis syndrome, intercurrent infection etc
2 Severe cognitive or psychiatric disorder in child or primary caregiver that hinder participation.
3 Previous regular yoga practice in the patient or caregiver in last 6 months.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Primary outcome is change in health related quality of life by PedsQOL 4.0 for patients and parents  Baseline and at 12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary outcome is change in parental stress by perceived stress scale  Baseline and at 12 weeks 
Change in child stress and anxiety by Revised Children’s Anxiety and depression
scale 25
 
Baseline and at 12 weeks 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   19/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  19/08/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Study Design- Quasi experimental study

Study duration- June 2025 to November 2026.

Intervention period- 12-week period, with pre- and post-intervention assessments.

Study Setting- The study will be conducted in the Paediatric haemato-oncology clinic and Paediatric ward in the Department of Paediatrics with a dedicated yoga instructor at the Employee State Insurance Corporation (ESIC) Model Hospital and PGIMSR, Basaidarapur, New Delhi in collaboration.

Sample Size

Taking the study by Bisht et al  as the parent study, the sample size will be determined based on a power analysis, aiming to detect a moderate effect size (Cohen’s d = 0.5) with 80% power and a significance level of 0.05. A minimum of 40 patient-caregiver dyads ( a total of 80 subjects) will be enrolled, accounting for a 20% dropout rate.

Bisht et al studied the impact of yoga based lifestyle intervention (YBLI) on psychological stress and quality of life in the parents of children with retinoblastoma with a sample size of 86 (43 dyads of both parents of retinoblastoma patients.) The study concluded that YBLI improves overall health and QOL and reduces psychological stress experienced by the parents of retinoblastoma patients.

Sampling Technique

A consecutive sampling method will be used. Eligible participants will be enrolled during routine outpatient or inpatient visits over a recruitment period of 15 months (leaving 3 months for follow-up).

Intervention  Participation will consist of  practicing of  yoga  for 12 weeks, consisting of:  Frequency of yoga practice is  5 sessions per week as per convenience of patients and parents at their home.    Duration of yoga is 10-30 minutes per session (less than 10 years – 10 minutes; greater than10 years-30 minutes) . Patients will be asked to do  Age-appropriate asanas (postures), pranayama (breathing exercises), and guided meditation. Sessions will be age and appropriate for disease stage.   Sessions will be led by certified yoga therapist and will be taught to the parents. Monitoring of compliance by keeping record of diary daily and video calls 3 times per week and interviewed physically 3 weekly.

Data Collection Demographic and clinical data (diagnosis, treatment phase, etc.) will be collected from medical records. Participants will complete questionnaires under supervision at two time points.. HRQoL assessments will be conducted at baseline (Week 0) and post-intervention (Week 12). If yoga is delayed due to any issue, the final assessment will be done at completion of 12 weeks of yoga therapy.

Statistical Analysis The data collected will be entered in Microsoft Excel and the analyses will be done using Statistical Package for Social Sciences (SPSS) version 25.0. Descriptive statistics will be used to summarize the demographic and clinical variables. The discrete variables will be presented as frequency and percentages whereas the continuous variables will be presented as mean (SD) or median (IQR). Paired t-tests (or Wilcoxon signed-rank tests for non-parametric data) will be used to assess within-group differences. Independent t-tests (or Mann–Whitney U tests) will be used to compare between-group differences. Multivariate linear regression will be used to control for confounders (e.g., age, treatment type). Significance will be set at p  less than  0.05.


 
Close